Potential uses for cord hood mesenchymal stem cells

Cell Journal

Volumn 15, Issue 4, 2014, Pages 274-281

  Zarrabi, Morteza ^a   Mousavi, Seyed Hadi ^b   Abroun, Saeid ^b   Sadeghi, Bahareh ^a  

^a Cord Blood Bank ^*  (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Cord blood; Mesenchymal stem cells; Transplantation

Indexed keywords

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CORD BLOOD MESENCHYMAL STEM CELL; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; NONHUMAN; PARKINSON DISEASE; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; SPINAL CORD INJURY; SYSTEMIC LUPUS ERYTHEMATOSUS; WOUND HEALING;

EID: 84891940378     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Perdikogianni C, Dimitriou H, Stiakaki E, Martirnianaki G, Kalmanti M. Could cord blood be a source of mesenchymal stromal cells for clinical use?. Cytotherapy. 2008; 10(5): 452-459.
2. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1): 235-242.
3. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004; 22(7): 1338-1345.
4. Panepucci RA, Siufi JL, Silva WA Jr, Proto-Siquiera R, Neder L, Orellana M, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004; 22(7): 1263-1278.
5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893): 41-49.
6. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem. 2006; 97(4): 744-754.
7. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bonemarrow. Blood. 2001; 98(8): 2396-2402.
8. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004; 22(7): 1330-1337.
9. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-317.
10. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000; 61(4): 364-370.
11. Chagraoui J, Lepage-Noll A, Anjo A, Uzan G, Charbord P. Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition. Blood. 2003; 101(8): 2973-2982.
12. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA. 2003; 100(5): 2397-2402.
13. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhauser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22(3): 377-384.
14. Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stemcells. Stem Cells. 2006; 24(2): 315-321.
15. Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol. 2007; 18(6): 846-858.
16. Flynn A, Barry F, O'Brien T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy. 2007; 9(8): 717-726.
17. Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, et al. Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells. 2008; 26(1): 146-150.
18. Wu LF, Wang NN, Liu YS, Wei X. 20. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone-marrow mesenchymal stem cells. Tissue Eng Part A. 2009; 15(10): 2865-2873.
19. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005; 23(2): 220-229.
20. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006; 91(8): 1017-1026.
21. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007; 25(11): 2886-2895.
22. Wu KH, Zhou B, Lu SH, Feng B, Yang SG, Du WT, et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem. 2007; 100(3): 608-616.
23. Bieback K, Klüter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther. 2007; 2(4): 310-323.
24. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010; 3(4): 248-269.
25. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant. 2007; 13(12): 1477-1486.
26. Meregalli M, Farini A, Torrente Y. Mesenchymal stem cells as muscle reservoir. J Stem Cell Res Ther. 2011; 1(2): 1000105.
27. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother. 2008; 8(8): 1193-1201.
28. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, et al. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis. 2007; 27(3): 339-353.
29. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy forischemic stroke in rats. Brain Res. 2008; 1229: 233-248.
30. Liao W, Zhong J, Yu J, Xie J, Liu Y, Du L, et al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhagerat: implications of anti-inflammation and angiogenesis. Cell Physiol Biochem. 2009; 24(3-4): 307-316.
31. Coutts M, Keirstead HS. Stem cells for the treatment of spinal cord injury. Exp Neurol. 2008; 209(2): 368-377.
32. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS One. 2008; 3(10): e3336.
33. Yasuhara T, Date I. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant. 2007; 16(2): 125-132.
34. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells. 2006; 24(1): 115-124.
35. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodentmodel of Parkinson's disease. Stem Cells. 2006; 24(3): 781-792.
36. Zhu X, Raina AK, Perry G, Smith MA. Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res. 2006; 3(4): 393-396.
37. Madeira A, Pommet JM, Prochiantz A, Allinquant B. SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor proteincytoplasmic subdomain. FASEB J. 2005; 19(13): 1905-1907.
38. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron. 2002; 35(3): 419-432.
39. Behl C. Oxidative stress in Alzheimer's disease: implications for prevention and therapy. Subcell Biochem. 2005; 38: 65-78.
40. Onyango IG, Khan SM. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. Curr Alzheimer Res. 2006; 3(4): 339-349.
41. Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, Sakamoto T, et al. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett. 2010; 481(1): 30-35.
42. Stéphan A, Laroche S, Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission andplasticity and causes memory deficits. J Neurosci. 2001; 21(15): 5703-5714.
43. Tsai KJ, Tsai YC, Shen CK. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med. 2007; 204(6): 1273-1280.
44. Li N, Feugier P, Serrurrier B, Latger-Cannard V, Lesesve JF, Stoltz JF, et al. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral bloodprogenitor cells and decrease their allostimulatory capacity. Exp Hematol. 2007; 35(3): 507-515.
45. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominanceand increase engraftment from double cord transplantation. Blood. 2004; 103(5): 1941-1948.
46. Bakhshi T, Zabriskie RC, Bodie S, Kidd S, Ramin S, Paganessi LA, et al. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal supportfor the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion. 2008; 48(12): 2638-2644.
47. Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev. 2011; 7(1): 195-207.
48. Kim JY, Jeon HB, Yang YS, Oh W, Chang JW. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J Stem Cells. 2010; 2(2): 34-38.
49. Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335(12): 860-863.
50. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001; 358(9277): 221-229.
51. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med. 2000; 6(3): 278-282.
52. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 2001; 292(5520): 1389-1394.
53. Yang L, Li S, Hatch H, Ahrens K, Cornelius JG, Petersen BE, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA. 2002; 99(12): 8078-8083.
54. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun. 2004; 325(3): 665-669.
55. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest. 2004; 84(5): 607-617.
56. Hori Y, Gu X, Xie X, Kim SK. Differentiation of insulin producing cells from human neural progenitor cells. PLoS Med. 2005; 2(4): e103.
57. Chao KC, Chao KF, Fu YS, Liu SH. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cordfor transplantation to control type 1 diabetes. PloS One. 2008; 3(1): e1451.
58. Koblas T, Harman SM, Saudek F. The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud. 2005; 2(4): 228-234.
59. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358(9): 929-939.
60. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010; 62(8): 2467-2475.
61. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007; 120(11): 936-939.
62. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376(9746): 1094-1108.
63. Liu Y, Mu R, Wang S, Long L, Liu X, Li R, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2010; 12(6): R210.
64. Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, et al. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis Rheum. 2007; 56(5): 1417-1423.
65. Atiyeh BS, Gunn SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005; 29(2): 131-148.
66. Luo G, Cheng W, He W, Wang X, Tan J, Fitzgerald M, et al. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived fromhuman umbilical cord blood. Wound Repair Regen. 2010; 18(5): 506-513.